Minimize

Welcome!

A closer look at the Theralase Q2 Financials and a look ahead on the cancer trials

Cory
August 30, 2016

Roger White, President and CEO of Theralase Technology joins us for a follow up on the recent Q2 financial statements. Cory and Roger go through some of the bigger line items to get a handle on the direction of sales for the TLC-2000. We also take a look at the next milestone for the cancer division and related trails.

Click here to read the Theralase news release on the Q2 financials.

Click download link to listen on this device: Download Show

Discussion
2 Comments
    Aug 30, 2016 30:34 PM

    The trend has been up this year but look at the monthly before you buy. This thing is having a hard time around the 32 cent range and fell off a cliff this week.

    Aug 30, 2016 30:59 PM

    Human trials are going to be significant.